
|Articles|June 14, 2007
ADHD pharmacotherapy: Prescribe with safety in mind and monitor results with vigilance
The keys to optimal use of psychostimulant and nonstimulant medications for attention deficit hyperactivity disorder are careful screening of patients, appropriate dosage regulation, and?most of all?close monitoring of both positive and adverse outcomes.
Advertisement
Advertisement
Advertisement
Advertisement
Trending on Contemporary Pediatrics
1
FDA approves centanafadine for ADHD in children, adolescents, and adults
2
Ensitrelvir now available in US for COVID-19 postexposure prophylaxis
3
Omalizumab outperforms multiallergen oral immunotherapy in multifood allergy trial
4
Pooled phase 3 data show early, consistent tapinarof cream responses across pediatric age groups in AD
5




